Stockreport

FDA accepts Acer Therapeutics' NDA and priority review for EDSIVO for the treatment of vEDS [Seeking Alpha]

Acer Therapeutics Inc.  (ACER) 
Last acer therapeutics inc. earnings: 3/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: acertx.com/investor-relations
PDF FDA accepts Acer Therapeutics' NDA and priority review for EDSIVO for the treatment of vEDS [Read more]